Francesc Moncho-Francés

7PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMicrofluidics and nanofluidicsCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicinePsychiatry (incl. psychotherapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 07, 2026
Hypophosphatemia after CAR-T cell therapy: a prospective study of inflammation, tubular injury and phosphate handling.

|May 13, 2026
Intra-Individual Variability of Urinary EGF and Clusterin, and Effect of Frozen Storage on Stability: Results from UVALID.

|Oct 08, 2025
Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction.

Francesc Moncho-Francés, Rafael Hernani, Isabel Juan-García

|Sep 10, 2025
The impact of metabolic dysfunction-associated steatotic liver disease (MASH) on the high risk of cardiovascular disease in CKD: interconnections and management.

Francesc Moncho, Salvador Benlloch, Jose Luis Górriz

|Feb 26, 2022
COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study.

Helena Garcia-Llana, Nayara Panizo, Lorena Gandía

|Nov 25, 2021
Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study.

Patricia Muñoz Ramos, Yohana Gil Giraldo, Vicente Álvarez-Chiva

Pageof 2

Frequent Collaborators

6 joint publications

Jose Luis Gorriz

2 joint publications

Luis D'Marco

2 joint publications

Juan F Navarro-González

2 joint publications

Jose Luis Piñana